Nikola Šobot

Major Adverse Cardiovascular Events After Implantation of Absorb Bioresorbable Scaffold: One-Year Clinical Outcomes

Zorislava Bajic, R. Babić, N. Ponorac, 2021 .

How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucose cotransporter 2 inhibitor in chronic coronary syndrome and heart failure in type 2 diabetes?

B. Stanetić, Tamara Kovačević Preradović, L. Kos, 2022 .

Bilateral Coronary Artery - Pulmonary Artery Fistula with Recurrent Ventricular Tachycardia: Case Report.

V. Ivanovic, M. Bikicki, Nikola Šobot, 2015, Srpski arhiv za celokupno lekarstvo.

Minocycline as heart conditioning agent in experimental type 2 diabetes mellitus — an antibacterial drug in heart protection

V. Jakovljevic, S. Mitrovic, S. Bolevich, 2022, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effects of Sulfur Amino Acids on Cardiodynamic Parameters of Isolated Rat Heart

V. Jakovljevic, S. Bolevich, D. Djuric, 2020, Serbian Journal of Experimental and Clinical Research.

Major adverse cardiovascular events after implantation of absorb bioresorbable scaffold: One-year clinical outcomes

Zorislava Bajic, N. Ponorac, Tanja Sobot, 2021, Scripta Medica.